Selection criteria for antifungals: the right patients and the right reasons.
The increasing number of new antifungal agents and their range of licensed indications mean that clinicians now have several pharmacological options for combating fungal infections. This paper briefly reviews the current available agents and seeks to introduce evidence that will help ensure optimal treatment for each type of fungal infection.
Chandrasekar
Pranatharthi
P
Division of Infectious Diseases, Wayne State University School of Medicine, Harper Hospital, Detroit, MI, USA. pchandrasekar@med.wayne.edu
D000935:Antifungal Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000097:blood / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D012307:Risk Factors; D016896:Treatment Outcome; D020096:Zygomycosis / Q000188:drug therapy
D000935:Antifungal Agents